• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性乳腺癌和卵巢癌(HBOC):BRCA1 和 BRCA2、林奇综合征、考登综合征和李-佛美尼综合征的临床特征和咨询。

Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.

机构信息

Division of Clinical Genetics, Feinberg School of Medicine of Northwestern University, Chicago, IL, USA.

出版信息

Obstet Gynecol Clin North Am. 2010 Mar;37(1):109-33, Table of Contents. doi: 10.1016/j.ogc.2010.03.003.

DOI:10.1016/j.ogc.2010.03.003
PMID:20494261
Abstract

This article provides an overview of the molecular changes associated with inherited gynecologic malignancies and the incorporation of this information in the counseling of individuals at increased risk for developing malignancies, as well as conventional and emerging approaches to the screening of the general population. Cancer genetic counseling and its role in women's health care is examined. The focus is hereditary breast and ovarian cancer; however, cancer predisposition caused by genes other than BRCA1 and BRCA2 is also considered. The aim is to provide a foundation for counseling based on fundamental knowledge of the genes and their clinical consequences. The reader is then guided through the mechanics of risk assessment for individual patients, concluding with the psychosocial implications of counseling.

摘要

本文概述了与遗传性妇科恶性肿瘤相关的分子变化,并介绍了如何将这些信息纳入对高风险个体的咨询中,以及如何对普通人群进行常规和新兴的筛查。本文还探讨了癌症遗传咨询及其在女性保健中的作用。重点是遗传性乳腺癌和卵巢癌,但也考虑了由 BRCA1 和 BRCA2 以外的基因引起的癌症易感性。目的是为基于基因及其临床后果的基本知识进行咨询提供基础。然后,本文指导读者对个体患者进行风险评估的机制,最后讨论咨询的心理社会影响。

相似文献

1
Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.遗传性乳腺癌和卵巢癌(HBOC):BRCA1 和 BRCA2、林奇综合征、考登综合征和李-佛美尼综合征的临床特征和咨询。
Obstet Gynecol Clin North Am. 2010 Mar;37(1):109-33, Table of Contents. doi: 10.1016/j.ogc.2010.03.003.
2
Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.妇科肿瘤学家协会教育委员会关于遗传性妇科癌症易感性风险评估的声明。
Gynecol Oncol. 2007 Nov;107(2):159-62. doi: 10.1016/j.ygyno.2007.09.031.
3
Hereditary breast cancer and genetic counseling in young women.年轻女性的遗传性乳腺癌与遗传咨询
Breast Cancer Res Treat. 2010 Sep;123 Suppl 1:7-9. doi: 10.1007/s10549-010-1050-5. Epub 2010 Aug 14.
4
Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.与BRCA1和BRCA2基因突变相关的遗传性乳腺癌卵巢癌综合征家族中女性接受预防性卵巢切除术后的腹腔内癌转移
Gynecol Oncol. 2005 May;97(2):457-67. doi: 10.1016/j.ygyno.2005.01.039.
5
[Clinical and molecular diagnosis of inherited breast-ovarian cancer].遗传性乳腺癌-卵巢癌的临床与分子诊断
J Gynecol Obstet Biol Reprod (Paris). 2003 Apr;32(2):101-19.
6
Screening and prevention of hereditary gynecologic cancers.遗传性妇科癌症的筛查与预防
Semin Oncol. 2007 Oct;34(5):406-10. doi: 10.1053/j.seminoncol.2007.07.004.
7
Breast and ovarian cancer genetics and prevention.乳腺癌和卵巢癌遗传学与预防
W V Med J. 2003 Sep-Oct;99(5):187-91.
8
[Specialized genetic counseling in pediatric and adult oncology patients].[儿科和成人肿瘤患者的专业遗传咨询]
Cas Lek Cesk. 2002;141(1):23-7.
9
Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.种族/族裔对遗传性乳腺癌和卵巢癌遗传咨询与检测的影响。
Breast J. 2009 Sep-Oct;15 Suppl 1:S56-62. doi: 10.1111/j.1524-4741.2009.00798.x.
10
Hereditary breast cancer: part I. Diagnosing hereditary breast cancer syndromes.遗传性乳腺癌:第一部分。遗传性乳腺癌综合征的诊断
Breast J. 2008 Jan-Feb;14(1):3-13. doi: 10.1111/j.1524-4741.2007.00515.x. Epub 2007 Dec 11.

引用本文的文献

1
Established Cancer Predisposition Genes in Single and Multiple Cancer Diagnoses.单发性和多发性癌症诊断中已确定的癌症易感基因。
JAMA Oncol. 2025 Aug 28. doi: 10.1001/jamaoncol.2025.2879.
2
Selective Killing of BRCA2-Deficient Ovarian Cancer Cells via MRE11 Blockade.通过 MRE11 阻断选择性杀死 BRCA2 缺陷型卵巢癌细胞。
Int J Mol Sci. 2023 Jun 30;24(13):10966. doi: 10.3390/ijms241310966.
3
Identification of BRCA1/2 mutation female carriers using circulating microRNA profiles.利用循环 microRNA 谱鉴定 BRCA1/2 基因突变女性携带者。
Nat Commun. 2023 Jun 8;14(1):3350. doi: 10.1038/s41467-023-38925-4.
4
Surgical Management for Transposed Ovarian Recurrence of Cervical Cancer: A Systematic Review with Our Experience.手术治疗宫颈癌卵巢移位复发:系统评价与我们的经验。
Curr Oncol. 2022 Sep 29;29(10):7158-7170. doi: 10.3390/curroncol29100563.
5
Novel Interactive Tool for Breast and Ovarian Cancer Risk Assessment (Bright Pink Assess Your Risk): Development and Usability Study.用于乳腺癌和卵巢癌风险评估的新型交互式工具(粉莓评估您的风险):开发和可用性研究。
J Med Internet Res. 2022 Feb 24;24(2):e29124. doi: 10.2196/29124.
6
Comparison of Patient Susceptibility Genes Across Breast Cancer: Implications for Prognosis and Therapeutic Outcomes.乳腺癌患者易感性基因的比较:对预后和治疗结果的影响。
Pharmgenomics Pers Med. 2020 Jul 27;13:227-238. doi: 10.2147/PGPM.S233485. eCollection 2020.
7
Screening of BRCA1/2 genes mutations and copy number variations in patients with high risk for hereditary breast and ovarian cancer syndrome (HBOC).遗传性乳腺癌和卵巢癌综合征(HBOC)高危患者的 BRCA1/2 基因突变和拷贝数变异筛查。
BMC Cancer. 2020 Aug 10;20(1):747. doi: 10.1186/s12885-020-07250-0.
8
Immunohistochemical Expression of BRCA1 Protein, ER, PR and Her2/neu in Breast Cancer: A Clinicopathological Study.乳腺癌中 BRCA1 蛋白、ER、PR 和 Her2/neu 的免疫组织化学表达:一项临床病理研究。
Asian Pac J Cancer Prev. 2020 Apr 1;21(4):1025-1029. doi: 10.31557/APJCP.2020.21.4.1025.
9
Pharmacokinetics and clinical response to single agent rucaparib in a dialysis dependent patient with BRCA associated breast and recurrent ovarian cancer.一名依赖透析的BRCA相关乳腺癌和复发性卵巢癌患者使用单药鲁卡帕尼的药代动力学及临床反应
Gynecol Oncol Rep. 2018 Oct 28;26:91-93. doi: 10.1016/j.gore.2018.10.011. eCollection 2018 Nov.
10
Role of Poly Adenosine Diphosphate Ribose Polymerase Inhibitors in Advanced Stage Ovarian Cancer.聚腺苷二磷酸核糖聚合酶抑制剂在晚期卵巢癌中的作用
Cureus. 2018 May 24;10(5):e2685. doi: 10.7759/cureus.2685.